NEW YORK STOCK EXCHANGE, INC. · LLY
-1.93% · -$21.78
Eli Lilly and Co

Eli Lilly and Co

Pharmaceuticals
$1,105.02
Veridion Score
BETAHIGH CONF · 5/6 factors
As of May 30, 12:21 PM EDT · LLY
Methodology
73/100
BUY BIAS

Composite intelligence score across six weighted factors. Higher score = stronger composite signal.

Score history: Coverage building
Institutional Flow · 90D
Corporate Insiders
SEC Form 4
30/ 100
-183.3M net shares (90d) · 12B / 2S
US Congress
Senate eFD + House STOCK Act
/ 100
no data
Wall Street Analysts
Sell-side consensus
76/ 100
11 SB · 19 B · 8 H · 1 S
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Insider · Congress · Wall Street flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: HIGH · 5/6 factors with data · Computed May 30, 12:21 PM EDT · Refreshes hourly
Veridion Score History · 90D

Composite trend over time

LOADING HISTORY…
REFRESHES DAILY
AI Analysis
BETA

Why is LLY moving today?

Analyzing news articles + insider activity + analyst signals…
About Eli Lilly and Co
PHARMACEUTICAL PREPARATIONS
Founded
Listed
1970
Employees
50K
HQ
US

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Open
$1,127.01
Previous close
$1,126.8
Day high
$1,132.66
Day low
$1,089.01
Market cap
$1.04T
IPO
1970-07-09
Country
US
Currency
USD
Data ledger
Quote and day range
As of May 29, 4:00 PM EDT
Source: Market data
Veridion Score
As of May 30, 12:21 PM EDT
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Loading quarterly statements…
Insider activity · 6M
Loading Form 4 filings…
Congress · 90D
Loading PTR filings…
Federal contracts

LLY contract awards, year to date.

Public federal awards linked to this ticker.

$52.1K
Refresh interval: 12hSource: Federal contract awards
Department of Veterans Affairs
$52.1K
F-18 AMYVID B+4

F-18 AMYVID B+4

May 19, 2026
Lobbying spend

LLY lobbying filings, year to date.

Registered lobbying filings matched to Eli Lilly and Co.

$6.3M
Refresh interval: 12hSource: LDA disclosure filings
Health Issues Trade (domestic/foreign)Trade (domestic/foreign) Health Issues Medicare/Medicaid Consumer Issues/Safety/Products Copyright/Patent/Trademark Taxation/Internal Revenue Code PharmacyPharmacy Health Issues
Filing
$3.8M
ELI LILLY AND COMPANY

ELI LILLY AND COMPANY

Apr 16, 2026
Filing
$2.2M
ELI LILLY AND COMPANY

ELI LILLY AND COMPANY

Jan 15, 2026
Filing
$120.0K
ELI LILLY AND COMPANY

CHECKMATE GOVERNMENT RELATIONS

Apr 15, 2026
Latest news · LLY
Refresh interval: 5 minutes · Source: Market news insights
Loading articles…
Analyst ratings
Loading consensus…
Options · Live
Loading options chain…
Related tickers

Cross-references from this score page.

Apprentice · 1 rail
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.